Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An update from Shanghai MicroPort MedBot (Group) Co., Ltd. Class H ( (HK:2252) ) is now available.
Shanghai MicroPort MedBot (Group) Co., Ltd. announced the resignation of Mr. Chen Xinxing as a non-executive director and audit committee member, effective April 30, 2025, as he intends to focus on other work commitments. The board expressed gratitude for his contributions and confirmed no disagreements with the board. Following his departure, the audit committee will be restructured to include Mr. Chung Wai Man, Dr. Li Minghua, and Mr. Yao Haisong, with Mr. Chung continuing as chairperson.
More about Shanghai MicroPort MedBot (Group) Co., Ltd. Class H
Shanghai MicroPort MedBot (Group) Co., Ltd. is a joint stock company based in China, operating in the medical technology industry. The company focuses on developing and providing innovative medical robotic solutions.
YTD Price Performance: 77.50%
Average Trading Volume: 11,808,072
Technical Sentiment Signal: Sell
Current Market Cap: HK$16.98B
For an in-depth examination of 2252 stock, go to TipRanks’ Stock Analysis page.